Back to search

Article

Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.

2022-04-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Despite the fast establishment of new therapeutic agents in the management of COVID-19 and large-scale vaccination campaigns since the beginning of the SARS-CoV-2 pandemic in early 2020, severe disesase-courses still represent a threat, especially to patients with risk factors. This indicates the need for alternative strategies to prevent respiratory complicatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
240d5b4f-d46e-523a-9abf-70f53b4a4f83
DOI
10.21203/rs.3.rs-1507210/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.DOI 10.21203/rs.3.rs-1507210/v1
Select a neighboring publication to make it the new centre.